Fiche publication
Date publication
mai 2026
Journal
Clinical colorectal cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr VERNEREY Dewi
,
Mme HENRIQUES Julie
Tous les auteurs :
Jehanno L, Henriques J, Samaille T, Loisel C, Cervantes B, Colle R, Vernerey D, André T, Cohen R
Lien Pubmed
Résumé
Immune checkpoint inhibitors (ICI) are standard for MSI-H/dMMR metastatic colorectal cancer (mCRC). We compared their efficacy and sought subgroups deriving greater benefit from ICI combination.
Mots clés
CTLA-4 inhibitor, Colorectal neoplasms, DNA mismatch repair, Immune checkpoint inhibitors, Ipilimumab, Microsatellite instability, Nivolumab, PD-1 inhibitors, Pembrolizumab, predictive factor
Référence
Clin Colorectal Cancer. 2026 05 22;:
